Please complete this short form to get in touch with a member of our team and we will get back to you as soon as we can.
Continuing healthcare (CHC) is a complex area of service delivery that requires robust management to ensure your provision is efficient and equitable for those with long-term complex health needs.
We help to empower patients, improve their experience and deliver personalised care through assessment, review and care planning with a focus on quality of care. We offer a flexible modular approach of solutions for each step of the full lifecycle of CHC and funded care pathways.
Our support includes:
Our key strengths and expertise:
As one of the largest providers of funded care services in the UK, we deliver services at scale, aligned to best practice and tailored to match all relevant frameworks and legislation while access to large datasets enables invaluable benchmarking and analysis of trends. We provide specialist multidisciplinary expertise and work in close partnerships with local authorities and care providers. Our support provides easy access to additional specialist capacity (such as in liberty protection safeguards) and utilises market leading technology for purchasing and case management to enable efficiency.
Find out more about our continuing healthcare services by accessing the resources below.
A large trust in the Midlands commissioned Arden & GEM’s clinical support service to provide specialist pharmacist resource to deliver diabetes and hypertension clinics at one of their hospital sites to help manage complex patients.
Arden & GEM’s Pharmacy Lead will be joining the NHS Medicines Optimisation Conference on 30 November 2022 to share the aims of the Discharge Medicines Service and successful approaches to implementation.
In this article for PM Healthcare Journal, Arden & GEM's Medicines Optimisation team describe how their collaborative work with Black Country and West Birmingham ICS has uncovered the barriers to implementing a Discharge Medicines Service with positive impact for staff engagement and referrals.
Arden & GEM’s experienced clinical services team has undertaken 150 LeDeR reviews in a professional, timely and compassionate manner, producing actionable recommendations for service improvement.
In this blog for Healthcare Leader, Arden & GEM's Senior IFR Nurse, Charlotte Nuttley, considers the role that clinical policy development and harmonisation can play in helping ICSs to achieve the Triple Aim, deliver the COVID-19 recovery programme and make difficult funding decisions.
In this article for the Journal of Pharmacy Management, Arden & GEM's medicines optimisation team share their five-point approach to engaging with practices during the COVID-19 pandemic.
An Arden & GEM medicines optimisation pharmacy lead, specialising in diabetes care, has contributed a new chapter on management of Type 1 diabetes to the latest edition of the pharmacy textbook, ‘Drugs in Use’.
A case study to evaluate the effectiveness of an innovation to enable people with complex care needs to be discharged from hospital has been published in the Wiley ‘Health and Social Care in the Community’ journal.
Commissioning and Continuing Healthcare leaders from across the country came together this September to attend a series of half-day workshops facilitated by leading healthcare experts.
We worked with our clients to develop a timely assessment programme, including the prioritisation of overdue reviews. Our approach has improved outcomes for patients, ensured compliance with the national framework, and has delivered savings for Clinical Commissioning Groups in Coventry and Warwickshire.
If you’d like to find out more about continuing healthcare, please contact us here: